Meeting program
Thursday, October 12
*All times are in EET.
08:45 - 09:00 EET Opening remarks
- A Vidovic (Serbia), D Antic (Serbia), D Coriu (Romania) & D Grujicic (Serbia)
09:00 - 10:30 EET Session 1: Acute myeloid leukemia - Diagnosis & therapy
Chairs: A Bogdanovic (Serbia) & H Bumbea (Romania)
- State-of-the-Art lecture
K Döhner (Germany) - Next Generation Sequencing in AML: to whom, why and when?
M Radić Antolić (Croatia) - Flt3 positive AML patients: Experience of single center
N Suvajdžić Vuković (Serbia) - How we can treat unfit AML patients?
A Vidovic (Serbia) - Quizartinib for newly diagnosed acute myeloid leukemia patients
A Cili (Albania) - Panel discussion
All speakers
10:30 - 10:45 EET Coffee break
10:45 - 12:15 EET Session 2: Acute myeloid leukemia - Therapies
Chairs: MC Ar (Türkiye) & S Trajkova (North Macedonia)
- State-of-the-Art lecture
B Huntly (United Kingdom) - Focusing on FLT3 inhibitors in acute myeloid leukemia
C Stancioaica (Romania) - Relapsed/refractory AML patients: Therapeutic options
S Anžej Doma (Slovenia) - Acute leukemia (M3) after liver transplantation
M Aliona (Moldova) - Thrombosis in acute leukemias
M Mitrović (Serbia) - Panel disucssion
All speakers
12:15 - 12:45 EET Satellite Symposium: Novartis
12:15 - 13:15 EET Lunch
13:15 - 14:45 EET Session 3: Acute lymphoblastic leukemia - Diagnosis & therapy
Chairs: I Urosevic (Serbia) & E Grouzi (Greece)
- State-of-the-Art lecture
J Trka (Czech Republic) - ALL - Let's start with morphology and immunophenotype
M Guenova (Bulgaria) - The place of MRD in the management of ALL
D Darapınar (Türkiye) - Assessment of T-cell receptor gene rearrangement as a method for post induction minimal residual disease monitoring in adult patients with T-cell acute lymphoblastic leukemia
N Ridova (North Macedonia) - Acute leukemia, associated with t(8;9)(p11;q33) and FGFR1 rearrangement: Diagnostic and therapeutic challenges
P Voykov (Bulgaria) - Panel discussion
All speakers
14:45 - 15:00 EET Coffee break
15:00 - 16:30 EET Session 4: Acute lymphoblastic leukemia - Therapies
Chairs: S Buruiana (Moldova) & A Ivanaj (Albania)
- State-of-the-Art lecture
M Mansour (United Kingdom) - The role of immune therapies in treatment of ALL patients
E Ünal İnce (Türkiye) - The role of immunotherapy in R/R ALL
B Todorova (Slovenia) - Chimeric Antigen Receptor T-Cell Therapy in Adult B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?
P Tsirigotis (Greece) - Management of side effects of novel drugs in ALL
V Blaslov (Croatia) - Panel discussion
All speakers
16:30 - 17:00 Closing remarks
- D Coriu (Romania), D Antic (Serbia) & A Vidovic (Serbia)
17:00 - 17:30 EET Satelite Symposium: Medica Linea
Back